Pressure BioSciences, Inc.

14 Norfolk Ave.
South Easton, MA 02375 USA
Phone
Fax
Click for website

Research Sector Medical Devices; Diagnostics

Summary Description Focuses on the development and commercialization of a platform technology called pressure cycling technology to control bio-molecular interactions.

Management Richard T. Schumacher, CEO & Founder; Dr. Edmund Ting - Senior Vice President of Engineering; Dr. Nathan P. Lawrence, Ph.D - Vice President of Marketing; Dr. Alexander Lazarev, Ph.D. - Vice President of Research and Development; Mr. Matthew Potter, Vice President of Sales

Click here for Financial Data
Keywords: Sample-preparation, cell-and-tissue-lysis, biomolecule-extraction, sample-processing, proteomics, genomics, metabolomics, lipidomics, transcriptomics, nucleic-acids, DNA, RNA, proteins, lipids, small-molecules, mass-spectrometry, PBIO, pathogen inactivation, protein purification, control of chemical reactions, immunodiagnostics

Comment


Updated: May 24, 2017


Description

Pressure Biosciences is a life sciences tools company focused on the development and sale of proprietary laboratory instrumentation and consumables based on our patented and enabling pressure cycling ......view more

Products / Services

Pressure Cycling Technology (PCT) uses rapid cycles of hydrostatic pressure between ambient and ultra high levels to control biomolecular interactions, allowing for a high degree of precision, reprod......view more

Technology / Differentiation

PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 4 foreign patents c...view more

Market / Customers

PBI serves academic laboratories; government agencies; and biotechnology, pharmaceutical, and life science companies.......view more


Competitors / Substitutes / Alternatives

Agilent Technologies Inc., BD Biosciences (privately held), Thermo Fisher Scientific, Inc....view more

Strategy

"The company has a sharp, strategic focus that we believe gives us a realistic opportunity to successfully reach our short and long-term business goals, which include: A significant increase in th...view more

Revenue / Funding

PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including genomic and proteomic sample preparation, pathogen inactivation, the control...view more

Status

-...view more

RELATED COMPANIES



    0000-00-00-10349